HLA-DRB5 Antikörper (AA 43-70) (PE)
-
- Target Alle HLA-DRB5 Antikörper anzeigen
- HLA-DRB5 (Major Histocompatibility Complex, Class II, DR beta 5 (HLA-DRB5))
-
Bindungsspezifität
- AA 43-70
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser HLA-DRB5 Antikörper ist konjugiert mit PE
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Spezifität
- This HLA-DRB5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 43-70 amino acids from the Central region of human HLA-DRB5.
- Aufreinigung
- Affinity purified
- Isotyp
- IgG
- Top Product
- Discover our top product HLA-DRB5 Primärantikörper
-
-
- Applikationshinweise
-
Approved: ELISA, IHC, WB
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- PBS, no preservatives added
- Konservierungsmittel
- Without preservative
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
- Haltbarkeit
- 6 months
-
- Target
- HLA-DRB5 (Major Histocompatibility Complex, Class II, DR beta 5 (HLA-DRB5))
- Andere Bezeichnung
- HLA-DRB5 (HLA-DRB5 Produkte)
- Synonyme
- HLA-DRB antikoerper, major histocompatibility complex, class II, DR beta 5 antikoerper, HLA-DRB5 antikoerper
- Hintergrund
-
Name/Gene ID: HLA-DRB5
Synonyms: HLA-DRB5, DR-9, DR beta-5, Dw2, HLA-DRB, Human leucocyte antigen DRB5, MHC class II antigen DRB1*9, MHC class II HLA beta chain, MHC HLA-DR-beta chain, Leukocyte antigen class II, DR2-beta-2, DR9, MHC class II antigen DRB5 - Gen-ID
- 3127
- Pathways
- T-Zell Rezeptor Signalweg, Positive Regulation of Peptide Hormone Secretion, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
-